SCHEMBL7797462

SCHEMBL7797462

CCC(=C(c1ccc(I)cc1)c1ccc(OCCN(C)C)cc1)c1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE1A P54750 8/20 1.00
PDE1B Q01064 8/20 1.00
PDE1C Q14123 8/20 1.00
ESR1 P03372 9/20 0.88
ESR2 Q92731 7/20 0.88
MAPT P10636 3/20 0.88
MEN1 O00255 3/20 0.88
TP53 P04637 3/20 0.88
CYP3A4 P08684 3/20 0.88
KMT2A Q03164 3/20 0.88
PGR P06401 2/20 0.88
ESRRG P62508 2/20 0.88
CYP1A2 P05177 2/20 0.88
CYP2D6 P10635 2/20 0.88
HTR6 P50406 2/20 0.88
NPC1 O15118 1/20 0.88
NR1I2 O75469 1/20 0.88
PRKD3 O94806 1/20 0.88
ABCB11 O95342 1/20 0.88
EGFR P00533 1/20 0.88

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1151532 1.00 PDE1A (1.00) PDE1APDE1BPDE1CESR1ESR2
SCHEMBL7797461 1.00 PDE1A (1.00) PDE1APDE1BPDE1CESR1ESR2
SCHEMBL2827282 1.00 PDE1A (1.00) PDE1APDE1BPDE1CESR1ESR2
SCHEMBL8767718 0.94 PDE1A (1.00) PDE1APDE1BPDE1CESR1ESR2
SCHEMBL8767725 0.94 PDE1A (1.00) PDE1APDE1BPDE1CESR1ESR2
SCHEMBL8767709 0.94 PDE1A (1.00) PDE1APDE1BPDE1CESR1ESR2
Tamoxifen SCHEMBL60433 0.94 ESR1 (0.95) PDE1APDE1BPDE1CESR1ESR2
Tamoxifen SCHEMBL60434 0.94 ESR1 (0.95) PDE1APDE1BPDE1CESR1ESR2
Tamoxifen SCHEMBL17262111 0.94 ESR1 (1.00) PDE1APDE1BPDE1CESR1ESR2
Tamoxifen SCHEMBL17262082 0.94 ESR1 (1.00) PDE1APDE1BPDE1CESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010047033-A1 Composition for and method of preventing or treating breast cancer PROTEIN TECHNOLOGIES INTERNATIONAL, INC. 2001-11-29 US disclosed
US-6300367-B1 Composition for and method of preventing or treating breast cancer PROTEIN TECHNOLOGIES INTERNATIONAL, INC. 2001-10-09 US disclosed
EP-0260066-B1 TAMOXIFEN DERIVATIVES NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1990-05-09 EP disclosed
US-4839155-A Iodotamoxifen derivatives and use for estrogen receptor-positive breast cancer detection and therapy NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1989-06-13 US disclosed